P53 PROTEIN EXPRESSION IN PUTATIVE PRECURSOR LESIONS OF EPITHELIAL OVARIAN-CANCER

被引:67
作者
HUTSON, R [1 ]
RAMSDALE, J [1 ]
WELLS, M [1 ]
机构
[1] ST JAMESS UNIV HOSP,DEPT PATHOL,LEEDS LS9 7TF,W YORKSHIRE,ENGLAND
关键词
P53; INCLUSION CYSTS; OVARY; CANCER;
D O I
10.1111/j.1365-2559.1995.tb01528.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
p53 protein expression has been studied in epithelial inclusion cysts adjacent to and contralateral to serous carcinoma of the ovary and compared to epithelial inclusion cysts associated with borderline tumours and in normal ovaries. Atypia was found in epithelial inclusion cysts in eight of the thirteen advanced (stage III) serous ovarian carcinomas. Of these eight with atypical epithelial inclusion cysts, five showed immunoreactivity for p53, In the borderline tumours and normal ovaries no atypia in such cysts was found, p53 expression was also seen more frequently in surface epithelium associated with ovarian serous adenocarcinoma (ten of 13) than in normal ovaries (one of 13). We postulate that focal areas of atypia (ovarian intra-epithelial neoplasia) in epithelial inclusion cysts are the precursors of ovarian malignancy. In some cases, at least, p53 protein expression may precede overt cytological abnormalities.
引用
收藏
页码:367 / 371
页数:5
相关论文
共 18 条
  • [1] OVEREXPRESSION OF THE P53 PROTEIN AND ALLELE LOSS AT 17P13 IN OVARIAN-CARCINOMA
    ECCLES, DM
    BRETT, L
    LESSELS, A
    GRUBER, L
    LANE, D
    STEEL, CM
    LEONARD, RCF
    [J]. BRITISH JOURNAL OF CANCER, 1992, 65 (01) : 40 - 44
  • [2] ALTERATION OF P53 IN OVARIAN-CANCER - ITS OCCURRENCE AND MAINTENANCE IN TUMOR PROGRESSION
    KIYOKAWA, T
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1994, 13 (04) : 311 - 318
  • [3] IMMUNOHISTOCHEMICAL DETECTION OF P53 PROTEIN IN BORDERLINE AND MALIGNANT SEROUS OVARIAN-TUMORS
    KLEMI, PJ
    TAKAHASHI, S
    JOENSUU, H
    KIILHOLMA, P
    NARIMATSU, E
    MORI, M
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1994, 13 (03) : 228 - 233
  • [4] KOHLER MF, 1993, OBSTET GYNECOL, V81, P643
  • [5] WILD-TYPE P53 IS A CELL-CYCLE CHECKPOINT DETERMINANT FOLLOWING IRRADIATION
    KUERBITZ, SJ
    PLUNKETT, BS
    WALSH, WV
    KASTAN, MB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) : 7491 - 7495
  • [6] P53 GENE ANALYSIS OF OVARIAN BORDERLINE TUMORS AND STAGE-I CARCINOMAS
    KUPRYJANCZYK, J
    BELL, DA
    DIMEO, D
    BEAUCHAMP, R
    THOR, AD
    YANDELL, DW
    [J]. HUMAN PATHOLOGY, 1995, 26 (04) : 387 - 392
  • [7] MARKS JR, 1991, CANCER RES, V51, P2979
  • [8] MAZARS R, 1991, ONCOGENE, V6, P1685
  • [9] P53 EXPRESSION, MUTATION, AND ALLELIC DELETION IN OVARIAN-CANCER
    MCMANUS, DT
    YAP, EPH
    MAXWELL, P
    RUSSELL, SEH
    TONER, PG
    MCGEE, JO
    [J]. JOURNAL OF PATHOLOGY, 1994, 174 (03) : 159 - 168
  • [10] MILNER BJ, 1993, CANCER RES, V53, P2128